Simulations Plus Stock Price. Everything You Need To Know About The Simulations Plus Stock!
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 157 full-time employees. The firm provides prediction of properties of molecules utilizing both artificial intelligence (AI) and machine-based technology. The company also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. The company offers approximately 13 software products for pharmaceutical research and development, such as GastroPlus, DDDPlus, MembranePlus, ADMET Predictor, MedChem Designer, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite and PKPlus. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and academic and regulatory agencies worldwide for use in the conduct of industry-based research. Its subsidiaries include Cognigen Corporation, DILIsym Services, Inc. and Lixoft.
Simulations Plus Stock Price. Everything You Need To Know About The Simulations Plus Stock! performance
- Employees 157
- Company HQ Lancaster
- Website https://www.simulations-plus.com/
- SLP Asset Type Common Stock
- SLP Market Capitalization 893.1M
- Earnings Per Share 0.52
- Dividends Per Share 0.24
- Dividend Date 2024-05-06
- Quarterly Earnings Growth 0
Simulations Plus is a leading provider of simulation and modeling software for the pharmaceutical and biotechnology industries. With a strong track record in developing innovative solutions, Simulations Plus has become a trusted partner for companies looking to streamline their drug development processes. If you’re a retail investor from Malaysia, Thailand, Indonesia, or Vietnam, and interested in investing in Simulations Plus, here’s what you need to know. Firstly, you should conduct thorough research on the company’s financials, market position, and growth prospects. Understanding the potential risks and rewards is crucial in making informed investment decisions. To invest in Simulations Plus, you can consider using Zorion, an investment platform that allows you to access real US stocks and pre-IPO companies. Zorion not only provides investment insights and recommendations tailored to retail investors from Malaysia, Thailand, Indonesia, and Vietnam, but also offers educational resources to help you enhance your investment knowledge. By leveraging Zorion’s platform, you can have the opportunity to invest in Simulations Plus and potentially benefit from the growth of the pharmaceutical and biotechnology industries. Remember to diversify your portfolio and consult with financial advisors if needed to ensure your investment aligns with your financial goals and risk tolerance. Investing always carries risks, so it’s important to stay informed, remain patient, and make decisions based on your own research and understanding. Start investing in Simulations Plus with Zorion today and unlock the potential for long-term financial growth. (Note: The content provided is for informational purposes only and does not constitute financial advice. Always do your own research and consider your personal circumstances before making investment decisions.)
